The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience

Neuro Oncol. 1999 Apr;1(2):152-61. doi: 10.1093/neuonc/1.2.152.

Authors

P K Duffner¹, M E Horowitz, J P Krischer, P C Burger, M E Cohen, R A Sanford, H S Friedman, L E Kun

Affiliation

¹ State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Roswell Park Center Institute, Buffalo, NY, USA.

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow Transplantation
Brain Neoplasms / drug therapy
Brain Neoplasms / mortality
Brain Neoplasms / radiotherapy
Brain Neoplasms / surgery
Brain Neoplasms / therapy*
Chemotherapy, Adjuvant / adverse effects
Child, Preschool
Combined Modality Therapy
Cranial Irradiation / adverse effects
Ependymoma / drug therapy
Ependymoma / mortality
Ependymoma / radiotherapy
Ependymoma / surgery
Ependymoma / therapy
Glioma / drug therapy
Glioma / mortality
Glioma / radiotherapy
Glioma / surgery
Glioma / therapy
Growth Disorders / etiology
Humans
Infant
Infant, Newborn
Medulloblastoma / drug therapy
Medulloblastoma / mortality
Medulloblastoma / radiotherapy
Medulloblastoma / surgery
Medulloblastoma / therapy
Multicenter Studies as Topic
Neuroectodermal Tumors, Primitive / drug therapy
Neuroectodermal Tumors, Primitive / mortality
Neuroectodermal Tumors, Primitive / radiotherapy
Neuroectodermal Tumors, Primitive / surgery
Neuroectodermal Tumors, Primitive / therapy
Pilot Projects
Pinealoma / therapy
Radiotherapy, Adjuvant / adverse effects
Salvage Therapy
Survival Rate
Treatment Outcome